These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 11348476)

  • 21. Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin.
    Zhao JF; Zhang YJ; Jin XH; Athar M; Santella RM; Bickers DR; Wang ZY
    J Invest Dermatol; 1999 Dec; 113(6):1070-5. PubMed ID: 10594754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
    Man I; Dawe RS; Ferguson J; Ibbotson SH
    Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relation between melanocortin 1 receptor genotype and experimentally assessed ultraviolet radiation sensitivity.
    Flanagan N; Ray AJ; Todd C; Birch-Machin MA; Rees JL
    J Invest Dermatol; 2001 Nov; 117(5):1314-7. PubMed ID: 11710950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of minimal phototoxic dose following 8-methoxypsoralen bath: maximal reaction on average after 5 days.
    Behrens-Williams S; Gruss C; Grundmann-Kollmann M; Peter RU; Kerscher M
    Br J Dermatol; 2000 Jan; 142(1):112-5. PubMed ID: 10651704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time course of 8-methoxypsoralen-induced skin photosensitization in PUVA-bath photochemotherapy.
    Reuther T; Gruss C; Behrens S; von Kobyletzki G; Neumann N; Lehmann P; Altmeyer P; Kerscher M
    Photodermatol Photoimmunol Photomed; 1997; 13(5-6):193-6. PubMed ID: 9542757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
    Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
    Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
    Man I; Dawe RS; Ferguson J; Ibbotson SH
    Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
    Calzavara-Pinton P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of PUVA bath phototoxicity.
    Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
    Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between bathing time and photosensitivity in 8-methoxypsoralen (8-MOP) bath PUVA.
    Dolezal E; Seeber A; Hönigsmann H; Tanew A
    Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):183-5. PubMed ID: 11019944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
    Schempp CM; Schöpf E; Simon JC
    Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response.
    Klosner G; Trautinger F; Knobler R; Neuner P
    J Invest Dermatol; 2001 Mar; 116(3):459-62. PubMed ID: 11231322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An action spectrum for the elicitation of erythema in skin persistently sensitized by photobound 8-methoxypsoralen.
    Ortel B; Gange RW
    J Invest Dermatol; 1990 Jun; 94(6):781-5. PubMed ID: 2355181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy.
    Ibbotson SH; Dawe RS; Dinkova-Kostova AT; Weidlich S; Farr PM; Ferguson J; Wolf CR; Smith G
    Br J Dermatol; 2012 Feb; 166(2):380-8. PubMed ID: 21967523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Miniature swine model of phototoxicity testing.
    Leigh H; Forbes PD; Lawson C; Kim DY; White D; Brown LD; Wehmeier DR; Liu J; Bouchard GF
    Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):34-41. PubMed ID: 22212001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of minimal phototoxic dose and skin type for determining initial UVA dose in oral liquid methoxsalen photochemotherapy for the treatment of psoriasis.
    Rafal ES; Hamilton TA; Gonzalez E
    J Invest Dermatol; 1991 Dec; 97(6):1048-52. PubMed ID: 1748814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of methoxsalen and other psoralens.
    de Wolff FA; Thomas TV
    Clin Pharmacokinet; 1986; 11(1):62-75. PubMed ID: 3512141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new liquid formulation of 8-methoxypsoralen: bioactivity and effect of diet.
    Levins PC; Gange RW; Momtaz-T K; Parrish JA; Fitzpatrick TB
    J Invest Dermatol; 1984 Feb; 82(2):185-7. PubMed ID: 6693780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
    Hofer A; Fink-Puches R; Kerl H; Quehenberger F; Wolf P
    Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentration and phototoxic effect of methoxsalen in patients with psoriasis.
    Swanbeck G; Ehrsson H; Ehrnebo M; Wallin I; Jonsson L
    Clin Pharmacol Ther; 1979 Apr; 25(4):478-80. PubMed ID: 428192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.